326 related articles for article (PubMed ID: 27914752)
1. Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.
Cruz MJ; Curull V; Pijuan L; Álvarez-Simón D; Sánchez-Font A; de Gracia J; Culebras M; Ferrer J
Arch Bronconeumol; 2017 Jun; 53(6):318-323. PubMed ID: 27914752
[TBL] [Abstract][Full Text] [Related]
2. [The clinical utility of asbestos body counts in bronchoalveolar lavage fluid].
Takabe K; Tsukada Y; Shimizu T; Takagiwa J; Hirayama M; Nakayama M; Miura H; Akabane H; Takayama S; Aida S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1196-204. PubMed ID: 9493446
[TBL] [Abstract][Full Text] [Related]
3. [The content of asbestos bodies in the bronchoalveolar fluid as a parameter of an increased pulmonary asbestos load].
Teschler H; Hoheisel G; Fischer M; Müller KM; Konietzko N; Costabel U
Dtsch Med Wochenschr; 1993 Dec; 118(48):1749-54. PubMed ID: 8253027
[TBL] [Abstract][Full Text] [Related]
4. Asbestos bodies in bronchoalveolar lavage in the 21st century: a time-trend analysis in a clinical population.
Nuyts V; Vanhooren H; Begyn S; Nackaerts K; Nemery B
Occup Environ Med; 2017 Jan; 74(1):59-65. PubMed ID: 27550908
[TBL] [Abstract][Full Text] [Related]
5. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage.
Teschler H; Konietzko N; Schoenfeld B; Ramin C; Schraps T; Costabel U
Am Rev Respir Dis; 1993 May; 147(5):1211-5. PubMed ID: 8484633
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of asbestos exposure via mineralogical analysis of bronchoalveolar lavage fluid].
Romeo R; Scancarello G; Cassano P; Cioni F; Bacaloni A; Sartorelli P
Med Lav; 2004; 95(1):17-31. PubMed ID: 15112744
[TBL] [Abstract][Full Text] [Related]
7. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
8. [Guidelines on asbestos-related pleuropulmonary disease].
Isidro Montes I; Abu Shams K; Alday E; Carretero Sastre JL; Ferrer Sancho J; Freixa Blanxart A; Monsó Molas E; Pascal Martínez I; Rodríguez Becerra E; Rodríguez Panadero F;
Arch Bronconeumol; 2005 Mar; 41(3):153-68. PubMed ID: 15766468
[No Abstract] [Full Text] [Related]
9. Asbestos fibers in bronchoalveolar lavage and lung tissue of former asbestos workers.
Teschler H; Friedrichs KH; Hoheisel GB; Wick G; Soltner U; Thompson AB; Konietzko N; Costabel U
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):641-5. PubMed ID: 8118631
[TBL] [Abstract][Full Text] [Related]
10. [Exposition markers: mineralogical analysis in the sputum and the bronchoalveolar lavage--asbestos bodies--uncoated fibres].
Billon-Galland MA
Rev Mal Respir; 2012 Apr; 29(4):521-8. PubMed ID: 22542409
[TBL] [Abstract][Full Text] [Related]
11. [The diagnostic value of asbestos bodies in mesotheliomas].
de Vuyst P; Dumortier P; Vande Weyer R; Walravens C; Rocmans P; Ketelbant P; Yernault JC
Rev Mal Respir; 1985; 2(5):295-9. PubMed ID: 3832198
[TBL] [Abstract][Full Text] [Related]
12. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid.
Schwartz DA; Galvin JR; Burmeister LF; Merchant RK; Dayton CS; Merchant JA; Hunninghake GW
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):684-8. PubMed ID: 1892311
[TBL] [Abstract][Full Text] [Related]
13. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: a light and scanning electron microscopic analysis of 18 cases.
Srebro SH; Roggli VL; Samsa GP
Mod Pathol; 1995 Aug; 8(6):614-21. PubMed ID: 8532693
[TBL] [Abstract][Full Text] [Related]
14. Analysis of asbestos bodies in BAL from subjects with particular exposures.
De Vuyst P; Dumortier P; Gevenois PA
Am J Ind Med; 1997 Jun; 31(6):699-704. PubMed ID: 9131224
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid.
De Vuyst P; Dumortier P; Moulin E; Yourassowsky N; Yernault JC
Am Rev Respir Dis; 1987 Nov; 136(5):1219-24. PubMed ID: 3314616
[TBL] [Abstract][Full Text] [Related]
16. Relevance of asbestos bodies in sputum.
Teschler H; Thompson AB; Dollenkamp R; Konietzko N; Costabel U
Eur Respir J; 1996 Apr; 9(4):680-6. PubMed ID: 8726931
[TBL] [Abstract][Full Text] [Related]
17. [Emerging pleuropulmonary diseases associated with asbestos inhalation].
Martínez C; Monsó E; Quero A
Arch Bronconeumol; 2004 Apr; 40(4):166-77. PubMed ID: 15030731
[No Abstract] [Full Text] [Related]
18. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
[TBL] [Abstract][Full Text] [Related]
19. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma.
Sebastien P; Armstrong B; Monchaux G; Bignon J
Am Rev Respir Dis; 1988 Jan; 137(1):75-8. PubMed ID: 3337472
[TBL] [Abstract][Full Text] [Related]
20. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases.
Roggli VL; Pratt PC; Brody AR
Br J Ind Med; 1986 Jan; 43(1):18-28. PubMed ID: 3947558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
